Treatment-associated decline in JAK2V617F allele burden in polycythemia vera: What does it mean?

被引:2
|
作者
Tefferi, Ayalew [1 ]
Pardanani, Animesh [1 ]
Gangat, Naseema [1 ]
机构
[1] Mayo Clin, Dept Med, Div Hematol, 200 First St SW, Rochester, MN 55905 USA
关键词
HYDROXYUREA; MUTATIONS; THERAPY; CALRETICULIN; RUXOLITINIB; JAK2(V617F); TRIAL; AGE;
D O I
10.1002/ajh.27375
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:1459 / 1461
页数:3
相关论文
共 50 条
  • [21] Clinical impact of mutated JAK2 allele burden reduction in polycythemia vera and essential thrombocythemia
    Guglielmelli, Paola
    Mora, Barbara
    Gesullo, Francesca
    Mannelli, Francesco
    Loscocco, Giuseppe Gaetano
    Signori, Leonardo
    Pessina, Chiara
    Colugnat, Ilaria
    Aquila, Raffaela
    Balliu, Manjola
    Maccari, Chiara
    Romagnoli, Simone
    Paoli, Chiara
    Nacca, Elena
    Fagiolo, Lorenzo
    Maffioli, Margherita
    Barbui, Tiziano
    Passamonti, Francesco
    Vannucchi, Alessandro M.
    AMERICAN JOURNAL OF HEMATOLOGY, 2024, 99 (08) : 1550 - 1559
  • [22] Concurrent JAK2V617F Mutation and MTHFRC677T Homozygosity in an Adolescent With Polycythemia Vera: Case Report and Discussion
    Ehmann, Michael R.
    Goodenough, Christopher J.
    Lotterman, Craig D.
    Warrier, Rajasekharan P.
    CLINICAL PEDIATRICS, 2013, 52 (07) : 671 - 674
  • [23] JAK2V617F/TET2 mutations: does the order matter?
    Pronier, Elodie
    Quivoron, Cyril
    Bernard, Olivier A.
    Villeval, Jean-Luc
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2011, 96 (05): : 638 - 640
  • [24] Practice Patterns in the Diagnosis and Treatment of Polycythemia Vera in the Post-JAK2 V617F Discovery Era
    Kander, Elizabeth M.
    Moliterno, Alison R.
    Rademaker, Alfred
    Streiff, Michael B.
    Spivak, Jerry L.
    Stein, Brady L.
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2016, 14 (10): : 1238 - 1245
  • [25] Modulation of JAK2 V617F allele burden dynamics by hydroxycarbamide in polycythaemia vera and essential thrombocythaemia patients
    Besses, Carlos
    Alvarez-Larran, Alberto
    Martinez-Aviles, Luz
    Mojal, Sergi
    Longaron, Raquel
    Salar, Antonio
    Florensa, Lourdes
    Serrano, Sergi
    Bellosillo, Beatriz
    BRITISH JOURNAL OF HAEMATOLOGY, 2011, 152 (04) : 413 - 419
  • [26] Features and allele frequency of JAK2 Exon 12-mutated polycythemia vera in comparison with JAK2 V617F-mutated disease
    Chuang, Chin-hsuan
    Kuo, Ming-chung
    Wu, Jin-hou
    Lin, Tung-liang
    Wang, Po-nan
    Chang, Yueh-shih
    Lin, Tung-hui
    Huang, Ting-yu
    Hung, Yu-shin
    Kao, Hsiao-wen
    Ou, Che-wei
    Chang, Hung
    Shih, Lee-yung
    ARCHIVES OF MEDICAL RESEARCH, 2025, 56 (02)
  • [27] Iron deficiency in JAK2 exon12 and JAK2-V617F mutated polycythemia vera
    Liu, Dan
    Xu, Zefeng
    Zhang, Peihong
    Qin, Tiejun
    Li, Bing
    Qu, Shiqiang
    Pan, Lijuan
    Cai, Wenyu
    Liu, Jinqin
    Wang, Huijun
    Sun, Qi
    Sun, Xiujuan
    Jiao, Meng
    Gao, Qingyan
    Shi, Zhongxun
    Huang, Huijun
    Huang, Gang
    Gale, Robert Peter
    Xiao, Zhijian
    BLOOD CANCER JOURNAL, 2021, 11 (09)
  • [28] Frequency and allele burden of CALR mutations in Chinese with essential thrombocythemia and primary myelofibrosis without JAK2V617F or MPL mutations
    Li, Ning
    Yao, Qiu-Mei
    Gale, Robert Peter
    Li, Jin-Lan
    Li, Ling-Di
    Zhao, Xiao-Su
    Jiang, Hao
    Jiang, Qian
    Jiang, Bin
    Shi, Hong-Xia
    Chen, Shan-Shan
    Liu, Kai-Yan
    Huang, Xiao-Jun
    Ruan, Guo-Rui
    LEUKEMIA RESEARCH, 2015, 39 (05) : 510 - 514
  • [29] Interferon α-2b gains high sustained response therapy for advanced essential thrombocythemia and polycythemia vera with JAK2V617F positive mutation
    Huang, Bin-Tao
    Zeng, Qing-Chun
    Zhao, Wei-Hong
    Li, Bing-Sheng
    Chen, Rui-lin
    LEUKEMIA RESEARCH, 2014, 38 (10) : 1177 - 1183
  • [30] Cardiac hypertrophy associated with myeloproliferative neoplasms in JAK2V617F transgenic mice
    Shi, Kaiyao
    Zhao, Wanke
    Chen, Yun
    Ho, Wanting Tina
    Yang, Ping
    Zhao, Zhizhuang Joe
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2014, 7